Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,463 | 13,437 | 16,917 | 18,402 | 19,061 |
| Receivables | 322 | 256 | 182 | 165 | 64 |
| TOTAL | $13,033 | $14,898 | $17,391 | $19,083 | $20,012 |
| Non-Current Assets | |||||
| PPE Net | 3 | 4 | 4 | 5 | 5 |
| Other Non-Current Assets | 175 | 7 | 0 | 0 | 0 |
| TOTAL | $178 | $10 | $4 | $5 | $5 |
| Total Assets | $13,212 | $14,908 | $17,395 | $19,088 | $20,018 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,473 | 1,273 | 647 | 977 | 306 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 9 |
| TOTAL | $1,473 | $1,273 | $647 | $977 | $365 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 18 | 475 | 0 | 0 | 0 |
| TOTAL | $N/A | $475 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,473 | $1,748 | $647 | $977 | $365 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,033 | 13,899 | 13,927 | 13,910 | 13,885 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -40,465 | -37,985 | -34,185 | -32,650 | -31,088 |
| Other shareholders' equity | -50 | -13 | 6 | 47 | 141 |
| TOTAL | $11,739 | $13,160 | $16,749 | $18,111 | $19,652 |
| Total Liabilities And Equity | $13,211 | $14,908 | $17,395 | $19,088 | $20,018 |